Observational studyInvestigational new drugs2021

Serum concentration of the CKD4/6 inhibitor abemaciclib, but not of creatinine, strongly predicts hematological adverse events in patients with breast cancer: a preliminary report.

Akimitsu Maeda et al.PubMed ↗Publisher ↗

No numbers read from the abstract.